Indonesia Strategy
Where to be positioned
Jayden Vantarakis
PT Macquarie Sekuritas
+62 (21) 2598 8310
Jayden.Vantarakis@Macquarie.com
September 2018
In preparing this research, we did not take into account the investment objectives, financial situation and particular
needs of the reader. Before making an investment decision on the basis of this research, the reader needs to
consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular
investment needs, objectives and financial circumstances. Please see disclaimer.
Macquarie Research | EQUITIES
Indonesia Strategy
PAGE 2
Macquarie Research | EQUITIES
Indonesia Strategy
• Exporters: ADRO, ITMG, INCO, INKP, UNTR Strongest case for EPS upgrades on IDR declines
• Select value: BBNI, LPPF, EXCL Attractive valuations for solid franchises
• Weighted average upside to our top picks of 26% (including dividend yield of 2.2%)
Market cap Share price Rating Target price Upside PER (x) EPS growth (%) ROE (%) P/BV (x) Div yld (%)
Ticker US$m Rp/sh Rp/sh % 18e 18e 18e 18e 18e
BBCA 39,734 23,900 O-P 25,200 6.6 21.6 17.2 19.3 3.9 1.2
UNVR 23,731 46,125 O-P 60,500 33.2 37.4 34.4 147.6 46.4 2.0
BBNI 8,960 7,125 O-P 10,000 44.5 8.2 18.9 15.9 1.3 4.1
UNTR 8,080 32,125 O-P 44,300 41.7 11.8 27.4 20.9 2.3 3.8
INKP 6,419 17,400 O-P 20,750 19.9 9.6 62.6 19.0 1.7 0.6
BDMN 4,330 6,700 O-P 9,700 46.8 15.2 14.6 10.5 1.5 2.0
ADRO 3,796 1,760 O-P 2,700 58.2 7.3 7.5 14.2 1.0 4.8
INCO 2,231 3,330 O-P 4,800 44.1 33.2 nmf 3.6 1.2 -
EXCL 2,112 2,930 O-P 4,200 43.3 65.6 (15.3) 2.2 1.4 -
ITMG 1,964 25,775 O-P 29,700 27.5 7.3 2.9 25.3 1.7 12.3
LPPF 1,321 6,725 O-P 11,000 70.6 9.4 6.1 75.7 6.3 7.0
Indonesia Strategy
Model
Modelportfolio
portfolio(IDR)
(IDR) MSCI
MSCIIndo
Indo(IDR)
(IDR)
35 32 32
23 22
25
15
(5)
(3)
(15) (11)
(13)
(25) (21)
Model MSCI Indo Model MSCI Indo Model MSCI Indo Model MSCI Indo
Portfolio Portfolio Portfolio Portfolio
Source: FactSet, Macquarie Research, September 2018; priced as at market close 12 September 2018 PAGE 4
Macquarie Research | EQUITIES
Indonesia Strategy
Top quartile by global sector Large cap ‘quality’ has outperformed ‘proxies’
Relative
% performance
100.0
90.0 185
80.0 165
70.0 145
60.0 125
50.0 105
40.0
85
30.0
65
20.0
45
10.0
25
-
Indonesia Strategy
20,000
• Reflation of key commodity export prices (coal, CPO, metals)
15,000
was a driver and placed at elevated US$27b gross per quarter
10,000 • Non commodity exports declining in absolute USD terms;
5,000
evidence of industrial competitiveness lacking
- • Asynchronous oil price hikes remains the key risk factor
(5,000)
Base metals, gold Rubber CPO Coal Net oil and gas
50,000
40,000
30,000
20,000
10,000
-
1Q05 1Q07 1Q09 1Q11 1Q13 1Q15 1Q17
Others Major commodities
Indonesia Strategy
7,000
34%
• Price interventions in fuel, coal, toll roads, cement, lending rates
6,000 and food suppress the CPI
5,000
• Rising current account deficit, expected at 2.3% of GDP in 18e
Jan-16
Jan-14
Jan-15
Jan-17
Jan-18
Apr-14
Oct-14
Apr-15
Oct-15
Apr-16
Oct-16
Apr-17
Oct-17
Apr-18
Jul-14
Jul-15
Jul-16
Jul-17
Jul-18
Widening driver of the trade deficit Forward outlook for oil and gas looks very poor
US$b
wells drilled
10 6.0%
1400 1318
5.0%
5
1172
1200 1127
4.0%
17
Exploration Exploitation
Source: Company data, Bloomberg, Macquarie Research, September 2018 PAGE 7
Macquarie Research | EQUITIES
Indonesia Strategy
Sep-06
Sep-08
Sep-10
Sep-12
Sep-14
Sep-16
Jan-04
Jan-06
Jan-08
Jan-10
Jan-12
Jan-14
Jan-16
Jan-18
May-05
May-07
May-09
May-11
May-13
May-15
May-17
1.0
Private external debt 17% of GDP EM concerns lifted yields across the curve
US$b
% % % Yield Investment grade
200
6 25.0 15.0
180 23.0
5 13.0 Brazil
21.0
160 12.0
19.0 11.0 Russia
4 Indonesia
140 17.0 8.6
8.3
9.0 India
120
3 15.0
8.0
100 13.0 7.0 Philippines
2 11.0 6.4
80 5.0
9.0 Singapore China
1 Vietnam
60 7.0 3.0 2.4 3.6 Malaysia
5.0
040 5.0 4.2 Thailand
1.0 US
Jan-13
Jan-07
Jan-08
Jan-09
Jan-10
Jan-11
Jan-12
Jan-14
Jan-15
Jan-16
Jan-17
Jan-18
Jul-07
Jul-08
Jul-09
Jul-10
Jul-11
Jul-12
Jul-13
Jul-14
Jul-15
Jul-16
Jul-17
2.9
2.3
-1.0
Private external debt % GDP (RHS) AAA AA A BBB BB B
Spread on US$ Indo 10yr sovereign yields vs US Treasuries
Indonesia Strategy
Sep-14
Dec-14
Sep-15
Dec-15
Sep-16
Dec-16
Sep-17
Dec-17
Sep-18
Dec-18
Jun-14
Jun-15
Jun-16
Jun-17
Jun-18
Mar-14
Mar-15
Mar-16
Mar-17
Mar-18
-
TPIA
TBIG
ISAT
SMRA
ASII
MYOR
JPFA
SMGR
CTRA
MNCN
BRPT
VIVA
TLKM
TOWR
EXCL
MAPI
BSDE
ICBP
PWON
UNVR
INDF
Indonesia Strategy
Election effects have been broadly positive 6 months into the event
7-39% outperformance vs EM in USD terms
50 % • The last 3 elections had market favourable outcomes with
40
39
relative outperformance against MSCI EM
30
19
• Jokowi’s VP choice was a compromise, narrowed race to two
20
10
tickets and headed off potentially divisive religious tactics
10 7 7
• Early published polls put Jokowi-Ma’ruf electability at 53% vs
-
(2) Prabowo-Sandi low 20%s
(10)
Parliamentary split of supporting tickets Registration for parliamentary candidates 4-17 Jul 2018
Indonesia Banks
Once the dust settles
Jayden Vantarakis
PT Macquarie Sekuritas
+62 (21) 2598 8310
Jayden.Vantarakis@Macquarie.com
September 2018
In preparing this research, we did not take into account the investment objectives, financial situation and particular
needs of the reader. Before making an investment decision on the basis of this research, the reader needs to
consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular
investment needs, objectives and financial circumstances. Please see disclaimer.
Macquarie Research | EQUITIES
Indonesia Banks
4.0
4.3
• Bank share de-rating has opened an opportunity
3.5 3.6
3.0
3.4 • We recently adjusted earnings to reflect limited loan re-pricing
3.4
2.5
3.5 for state banks, a flatter credit charge profile and slower loan
2.0 2.1
1.9 1.7
2.3 1.9 growth (11% in 19e)
1.6 1.7
1.5 1.5
1.2 1.2
1.0 1.1
1.0
0.5
0.8 • BCA resilient ROA 2.8-3.0%. 6x book growth over a decade.
BCA BRI Mandiri BNI Danamon BTN
US$3bn surplus capital, positive leverage to rising rates and
+/- 1 std. dev Average Trading
privately-owned
Book compounding of the major banks • Danamon M&A tender offer into end-18, underlying business
% BRI - 6.3x
in 10 yrs
improvements
20% Cagr
BCA - 5.9x
600
in 10 yrs • BNI under-appreciated Corporate franchise at an appealing
20% Cagr
500 valuation
400
BNI - 3.8x in
300
10 yrs 14%
Cagr • We lifted BRI to Outperform on valuation grounds
Mandiri - 3.6x
200 in 10 yrs 14%
Cagr
• Neutral on Mandiri at current levels
100 • BTN is our key sell idea on rates
10 11 12 13 14 15 16 17 18e 19e 20e
Indonesia Banks
41 3.7
5.0
40
22 -
20 10
6
2 0 (5.0)
- (5.1) (5.9)
(2) (10.0)
(4)
(20) (11) (11)
(15.0)
(14.2) (14.3)
(40) (28)
(20.0)
BNI BCA BRI Danamon Mandiri BTN BCA BNI Danamon Mandiri BRI BTN
Bear Bull
Lower bound - full restructured loan coverage Upside - optimised at 15.5% CET-1 % Average
Adj BPS Target ROE Fair P/B Fair value Adj BPS Free capital Target ROE Fair P/B Fair value Fair value
Mid-19e 3-yr x Rp/sh Mid-19e Mid 19e 3-yr x Rp/sh Rp/sh
BCA 5,764 22.5% 4.2 24,384 5,764 854 22.5% 4.2 25,238 24,811
BRI 1,509 17.3% 1.9 2,857 1,113 452 23.6% 2.8 3,544 3,201
Mandiri 3,188 16.0% 1.6 5,673 3,425 539 17.6% 1.9 6,996 6,335
BNI 5,707 16.8% 1.8 10,027 5,274 906 19.1% 2.1 12,033 11,030
BTN1 1,376 14.6% 1.3 1,810 2,094 - 12.8% 1.1 2,245 2,028
Danamon2 4,735 14.5% 1.4 6,456 4,735 263 14.5% 1.4 6,719 6,588
1 For BTN we apply a 13% dilution factor for expected additional capital required in 20e
2 Danamon is based on 2.1x 3Q18 P/BV as we assume a cash offer for minorities through the MUFG takeover proceedings
PAGE 13
Source: Macquarie Research, FactSet consensus, Company data, September 2018
Macquarie Research | EQUITIES
Indonesia Banks
9.6
• QR code standardization by 4Q18 the next milestone
10.0 3.1
8.0 2.4 • Leading banks on consumer tech BCA, BRI, Mandiri
8.0
6.5
6.0
1.7
3.0 • BNI the market leader on Corporate Cash Management
5.2 1.1 2.6
4.4 2.0
4.0 3.4
0.7
1.3
1.6 • BCA and Mandiri processing of major tech platform payments
2.5 1.2
2.0
1.9 0.8
3.8 4.2 4.7 5.2
• We estimate each 25bp onshore risk-free rate hike adds
3.2
US$3.6bn NPV to BCA’s transactional franchise
2.1 2.6
1.5 1.7
0.0
09 10 11 12 13 14 15 16 17
ATM Internet Mobile
Market share of Corporate cash management Top 4 dominated digital transactions in FY17
BCA
16% Mandiri
20% BRI
20%
BRI Mandiri
19% 21%
PAGE 14
Source: Company data, Macquarie Research, September 2018
Macquarie Research | EQUITIES
Indonesia Banks
Just ‘over the hump’ on asset quality, does recent volatility cause fresh concerns?
State bank total impaired loans declining
%
12
10
• Absolute restructured and non performing (‘impaired’) loans
level stabilizing and starting to decline in percentage terms
8
6
• Banks working through these portfolios keeping credit
4
charges elevated for next 1-2 years
2 • BCA and Danamon better placed than state banks to weather
-
a further economic downturn
PAGE 15
Source: Company data, Macquarie Research, September 2018
Macquarie Research | EQUITIES
Indonesia Banks
19.3
19.9 20.1 20.2 20.1 • Private banks leading efficiency drive, in particular Danamon
20 18.1
2.2 2.1 2.0 1.8
16.2
2.2
2.2
1.7
1.4 1.3
1.0
1.2
1.0
1.0
1.0 • State bank employee and branch expansion ongoing
14.1 2.0 1.0
15 1.8 1.0
11.3
12.0 1.8
1.5
1.7
0.9
0.9
• Fee income tailwinds for BRI and BCA
1.6
10 1.6 0.9
1.5
1.5 0.9
0.8 15.3 15.7 16.1 16.3
13.2 14.4
11.6
5 9.9
7.4 8.1
-
08 09 10 11 12 13 14 15 16 17
State banks BCA Danamon Other mid-tier banks
- 0.5
08 09 10 11 12 13 14 15 16 17 10 11 12 13 14 15 16 17 18e 19e 20e
State banks BCA Danamon Other mid-tier banks
BNI BRI Mandiri BCA
PAGE 16
Source: Company data, Macquarie Research, September 2018
Macquarie Research | EQUITIES
Indonesia Banks
BCA and CIMB Niaga most attractive offers Risk Weights lowered, LTVs raised
% pa % RWA
14 50 45
13 45 40
40 35 35
12 Mandiri Maybank
BRI 35
11 30 25
10 25 20
BNI 20
9
15
8 BTN 10
7 5
BCA % LTV
0
6 CIMB 0 50 55 60 65 70 75 80 85 90 95 100
Niaga year
5 New Old
1 2 3 4 5 6 7+
PAGE 17
Source: Company data, Bank Indonesia, Macquarie Research, September 2018
Macquarie Research | EQUITIES
Indonesia Banks
-
0.4 • ROE at 16% for 1.2x P/BV is very attractive, priced at similar
BNI Mandiri BRI
levels to BTN but a much stronger franchise
Average ROA Average Credit Charge
44% 45% 6
2.0%
5
1.0% 40%
4
0.0% 35%
10 11 12 13 14 15 16 17 18e 19e 20e
PAGE 18
Source: Company data, Macquarie Research, September 2018
Macquarie Research | EQUITIES
Indonesia Banks
80% of loans to less risky segments Credit RWA optimization upside 3.1ppt to CET-1
Other
consumer Net loans %
2% 4Q14 to 2Q18 21.0
Small (ex
Payroll
KUR) 20.0 Moves RWA intensity
Loans
3%
12% in Corporate/Medium
KUR small Corporate - 19.0 to same base as
business loans Infrastructure
32%
Mandiri +3.1
8%
18.0
19.8
17.0 -0.4
Medium
18% Corporate -
Plantations 16.0 17.2
Corporate & 14%
SOE (other)
11% 15.0
2Q18 IFRS-9 Impact Credit RWA Potential
optimisation
PAGE 19
Source: Company data, Macquarie Research, September 2018
Macquarie Research | EQUITIES
Indonesia Banks
Danamon – Meaningful steps taken on merger, we estimate 45% upside from here
Asymmetric payoff
Rp/sh
10,000 +45% 9,731
Average M&A control multiple 2.6x P/BV Improvements on opex and funding at the core bank
P/B (x)
8.0% Rpt 250
6.0
7.5%
5.0 200
BII 7.0%
Ekonomi 6.8%
4.0 Saudara 6.5% 150
Permata Lippo Sahabat 6.0%
3.0 NISP Lippo
5.5% 100
BII Niaga
2.0 Mutiara Anda Danamon
Niaga Buana 5.0% 5.0%
50
Danamon 4.5%
1.0 Windu
BCA
4.0% 0
1Q07
3Q07
1Q08
3Q08
1Q09
3Q09
1Q10
3Q10
1Q11
3Q11
1Q12
3Q12
1Q13
3Q13
1Q14
3Q14
1Q15
3Q15
1Q16
3Q16
1Q17
3Q17
-
Jun-00 Jun-02 Jun-04 Jun-06 Jun-08 Jun-10 Jun-12 Jun-14 Jun-16 Jun-18
PAGE 20
Source: Company data, Macquarie Research, September 2018
Macquarie Research | EQUITIES
Indonesia Banks
BCA - Ready for rising rates, but the market largely appreciates that already
12mth NIM sensitivity to each +25bps
bps
15.0
Top 4 Mid Tier
• Core bank 30% ROE with US$3bn surplus equity
9.3
10.0
6.3
4.9
• Most positively disposed to rising domestic rates. The market
5.0
1.0
2.1 largely gets this, stock has been resilient
-
• Mortgage leader, albeit shorter promo tenor and rates rising
(5.0)
(5.3)
• Least directly afflicted by populist Gov’t policy
(10.0)
• System is consolidating. Panin or Permata EPS accretive at
(10.7)
(15.0) 2-3x P/BV acquisition multiples, though unlikely BCA participates
BCA Mandiri BNI BRI Danamon BTN Coverage
30% 29.6%
3.3%
25% 3.4%
20% 17.8% 5.1%
15%
10%
5%
0%
4Q17a 17.5% Tier 1 Credit RWA 15.5% Tier 1 Optimised
optimisation
PAGE 21
Source: Company data, Macquarie Research, September 2018
Macquarie Research | EQUITIES
Indonesia Banks
PAGE 22
Source: Company data, Macquarie Research, September 2018
Macquarie Research | EQUITIES
Indonesia Banks
1%
• Risk reward looks balanced at current levels
3.0%
2.5%
0% • Credit charges probably settle out at current levels; unlikely to
2.0%
-1%
go back to net zero
-2%
1.5%
-3% • Funding position less stable than peers based on LCR
1.0%
-4% disclosures. Highest reliance on wholesale discretionary
0.5% -5% funds in absolute terms
0.0% -6%
1Q07 1Q08 1Q09 1Q10 1Q11 1Q12 1Q13 1Q14 1Q15 1Q16 1Q17 • Stock a third more expensive than BNI on multiples with less
ROA Net credit charge (RHS)
potential upside to assumptions (credit, margin)
Indonesia Banks
Valuation matrix
BCA BRI Mandiri BNI BTN Danamon
Ticker BBCA IJ BBRI IJ BMRI IJ BBNI IJ BBTN IJ BDMN IJ
Market Cap US$m 39,337 23,961 19,860 8,870 1,789 4,287
ADV US$m 21.7 27.2 16.3 9.3 3.6 1.6
Price IDR/sh 23,900 2,910 6,375 7,125 2,530 6,700
Target IDR/sh 25,200 3,200 6,120 10,000 2,000 9,700
Recommendation O-P O-P N O-P U-P O-P
19e Div yield % 1.6 3.8 2.7 4.9 2.3 2.4
12-mth TSR % 7.1 13.8 (1.3) 45.2 (18.6) 47.2
ROE %
16a 20.4 20.2 10.3 13.9 15.9 7.6
17a 19.1 18.5 12.5 14.7 14.8 9.9
18e 19.3 17.4 14.2 15.9 13.6 10.5
19e 20.0 16.3 14.7 16.4 12.7 10.6
P/E x
16a 28.6 13.7 21.5 11.7 10.2 24.1
17a 25.3 15.4 15.0 9.7 8.8 17.4
18e 21.6 11.8 12.3 8.2 8.6 15.2
19e 18.1 11.4 10.9 7.3 8.3 14.1
P/B x
16a 5.2 2.5 2.0 1.5 1.4 1.8
17a 4.5 2.2 1.8 1.3 1.2 1.7
18e 3.9 1.9 1.7 1.3 1.1 1.5
19e 3.4 1.8 1.5 1.1 1.0 1.4
PAGE 24
Source: Macquarie Research, Factset, September 2018. Priced as at close 12 September 2018
Macquarie Research | EQUITIES
Indonesia Mining
Own exporters
Jayden Vantarakis
PT Macquarie Sekuritas
+62 (21) 2598 8310
Jayden.Vantarakis@Macquarie.com
September 2018
In preparing this research, we did not take into account the investment objectives, financial situation and particular
needs of the reader. Before making an investment decision on the basis of this research, the reader needs to
consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular
investment needs, objectives and financial circumstances. Please see disclaimer.
Macquarie Research | EQUITIES
Indonesia Mining
90.0 • Cash margin less due to cost inflation, higher strip ratios.
80.0 PTBA best shielded
70.0
• Thermal coal forecast US$107/t in FY18e and US$85/t in
60.0
FY19e
50.0
• DMO is more than priced in at current levels in our view
40.0
30.0
Cash margin improvement led by PTBA ITMG reserves uplift also a positive
US$/t mt
40.0 450
400 Acquisition
35.0
350
30.0
300
Reserves
25.0 upgrade
250
20.0 200
15.0 150
10.0 100
50
5.0
0
-
PAGE 26
Source: Company data, Macquarie Research, September 2018
Macquarie Research | EQUITIES
Indonesia Mining
25,000
• Positive operating leverage in 19e beyond cost inflation
rising
20,000
operating
leverage
• Only major commodity with decent long-run demand story
15,000
from Electric Vehicles
10,000 • Divestment 20% should clear an overhang
5,000
-
10a 11a 12a 13a 14a 15a 16a 17a 18e 19e 20e 21e 22e
85 88 88 88 88 88
80 83
18,000
17,000 81
75 79
77 78 77 78 78
76 76
70
72
71
14,000 65
67 67
12,200
60
55
10,000 07 08 09 10 11 12 13 14 15 16 17 18e 19e 20e 21e 22e 23e 24e 25e
Spot Macquarie LR Est Discounted into the
stock Production Rated capacity
PAGE 27
Source: Company data, Macquarie Research, September 2018
Macquarie Research | EQUITIES
Indonesia Mining
Valuation Matrix
Company Mkt cap Price Target Rating 12-mth PE (x) EV/Ebitda (x) P/BV (x) Div yld (%) ROE (%)
Name Ticker (US$m) (LCY) (LCY) TSR (%) 18e 19e 18e 19e 18e 19e 19e 19e
Coal ITM ITMG IJ 1,973 25,775 29,700 O-P 27.8 7.6 7.9 3.5 3.6 1.7 1.8 12.5 22.1
Adaro ADRO IJ 3,742 1,760 2,700 O-P 58.1 7.4 7.4 2.8 2.7 1.0 0.9 4.7 12.7
Bukit Asam PTBA IJ 3,084 3,940 4,850 O-P 30.2 7.1 9.2 4.5 5.7 2.6 2.4 7.1 26.8
Average 8,800 41.5 7.4 8.2 3.6 4.0 1.7 1.6 7.3 19.7
Nickel Vale Indo INCO IJ 2,312 3,330 4,800 O-P 45.7 35.6 15.3 10.0 6.1 1.2 1.2 1.6 7.8
Antam ANTM IJ 1,511 890 - N-R - 50.0 42.8 11.9 11.1 1.1 1.1 - 2.6
Average 3,822 41.3 26.2 10.7 8.1 1.2 1.2 1.0 5.8
Total 12,622 17.6 13.6 5.7 5.2 1.5 1.5 5.4 15.5
PAGE 28
Macquarie Research | EQUITIES
Other sectors
Key thoughts on major stocks from our team
In preparing this research, we did not take into account the investment objectives, financial situation and particular
needs of the reader. Before making an investment decision on the basis of this research, the reader needs to
consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular
investment needs, objectives and financial circumstances. Please see disclaimer.
Macquarie Research | EQUITIES
Unilever Indonesia
Quality, resilient margin over various cost pressures. Valuation to remain premium
UNVR margin resiliency in the past 2 decades Domestic funds provided structural support on valuation
60% 45%
Domestic investors owned
50% 43% of UNVR free float
40% (Jul’18).
40% Despite cost pressures such as rupiah
depreciation, raw material increase, inflation in
30% 2005/08/11/13/15 35%
20%
30%
10%
0% 25%
Decent profit growth with consistently superior ROE • UNVR Indo launched several new products in new
subcategory to gain back market share in Personal care.
30% 160%
We think 1H18 is the bottom of its operational performance.
25%
20% 120% • Ytd UNVR increased price by almost 2%, we estimate price
15% increase needed to offset cost increase is 2.1%-2.5%.
80%
10% • Growing domestic funds continue to provide structural
5% 40% support to UNVR valuation, due to scarcity of quality in the
0% consumer space and UNVR large index weight.
-5% 0%
09 10 11 12 13 14 15 16 17 18e 19e
CMPC
58%
5% UPM
4% Others
3%
As at end FY17
INKP - improving profitability and lower gearing • Beneficiary of China’s waste paper import restrictions that
200% 18% 18% 20%
caused lower input cost and higher export prices for INKP.
17%
180% 18%
• Fully integrated structure, USD earner, and MSCI
160% 16%
140%
14%
14%
inclusion gather more attention and liquidity.
120% 10%
9%
12%
• The group increased ASP across its paper product by
100% 10%
80%
7%
8%
4%-5% in September, should support stronger 4Q18
5%
60% 6% numbers.
40% 2% 4%
20%
1% 1%
2%
• INKP IJ, OP, Rp20,750/sh, implies 8x 19PE and 7x
0% 0% EV/Ebitda, reflecting a 20% disc to peers.
10 11 12 13 14 15 16 17 18e 19e 20e
Astra International
Industry vs. Astra 3-month rolling volume growth Non-Auto to drive ASII earnings
United Tractors
PAGE 33
Macquarie Research | EQUITIES
PAGE 34
Macquarie Research | EQUITIES
Indonesia Telecoms
3M14
6M14
9M14
3M15
6M15
9M15
3M16
6M16
9M16
3M17
6M17
9M17
3M18
2013
2014
2015
2016
Important Disclosures:
PAGE 36
Macquarie Research | EQUITIES
Important Disclosures:
Company-Specific Disclosures:
Important disclosure information regarding the subject companies covered in this report is available at www.macquarie.com/research/disclosures.
Analyst Certification:
We hereby certify that all of the views expressed in this report accurately reflect our personal views about the subject company or companies and its or their securities. We also certify that no part
of our compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. The Analysts responsible for preparing this report receive
compensation from Macquarie that is based upon various factors including Macquarie Group Ltd total revenues, a portion of which are generated by Macquarie Group’s Investment Banking
activities.
General Disclaimers:
Macquarie Securities (Australia) Ltd; Macquarie Capital (Europe) Ltd; Macquarie Capital Markets Canada Ltd; Macquarie Capital Markets North America Ltd; Macquarie Capital (USA) Inc;
Macquarie Capital Limited, Taiwan Securities Branch; Macquarie Capital Securities (Singapore) Pte Ltd; Macquarie Securities (NZ) Ltd; Mazi Macquarie Securities (RF) (Pty) Ltd; Macquarie Capital
Securities (India) Pvt Ltd; Macquarie Capital Securities (Malaysia) Sdn Bhd; Macquarie Securities Korea Limited and Macquarie Securities (Thailand) Ltd are not authorized deposit-taking
institutions for the purposes of the Banking Act 1959 (Commonwealth of Australia), and their obligations do not represent deposits or other liabilities of Macquarie Bank Limited ABN 46 008 583 542
(MBL) or MGL. MBL does not guarantee or otherwise provide assurance in respect of the obligations of any of the above mentioned entities. MGL provides a guarantee to the Monetary Authority
of Singapore in respect of the obligations and liabilities of Macquarie Capital Securities (Singapore) Pte Ltd for up to SGD 35 million. This research has been prepared for the general use of the
wholesale clients of the Macquarie Group and must not be copied, either in whole or in part, or distributed to any other person. If you are not the intended recipient you must not use or disclose the
information in this research in any way. If you received it in error, please tell us immediately by return e-mail and delete the document. We do not guarantee the integrity of any e-mails or attached
files and are not responsible for any changes made to them by any other person. MGL has established and implemented a conflicts policy at group level (which may be revised and updated from
time to time) (the "Conflicts Policy") pursuant to regulatory requirements (including the FCA Rules) which sets out how we must seek to identify and manage all material conflicts of interest. Nothing
in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any transaction. In preparing this research, we did not take into
account your investment objectives, financial situation or particular needs. Macquarie salespeople, traders and other professionals may provide oral or written market commentary or trading
strategies to our clients that reflect opinions which are contrary to the opinions expressed in this research. Macquarie Research produces a variety of research products including, but not limited to,
fundamental analysis, macro-economic analysis, quantitative analysis, and trade ideas. Recommendations contained in one type of research product may differ from recommendations contained in
other types of research, whether as a result of differing time horizons, methodologies, or otherwise. Before making an investment decision on the basis of this research, you need to consider, with
or without the assistance of an adviser, whether the advice is appropriate in light of your particular investment needs, objectives and financial circumstances. There are risks involved in securities
trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international
investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. This research is based on information
obtained from sources believed to be reliable but we do not make any representation or warranty that it is accurate, complete or up to date. We accept no obligation to correct or update the
information or opinions in it. Opinions expressed are subject to change without notice. No member of the Macquarie Group accepts any liability whatsoever for any direct, indirect, consequential or
other loss arising from any use of this research and/or further communication in relation to this research. Clients should contact analysts at, and execute transactions through, a Macquarie Group
entity in their home jurisdiction unless governing law permits otherwise. The date and timestamp for above share price and market cap is the closed price of the price date. #CLOSE is the final price
at which the security is traded in the relevant exchange on the date indicated. Members of the Macro Strategy team are Sales & Trading personnel who provide desk commentary that is not a
product of the Macquarie Research department or subject to FINRA Rule 2241 or any other regulation regarding independence in the provision of equity research.
PAGE 37
Macquarie Research | EQUITIES
Important Disclosures:
Country-Specific Disclaimers:
Australia: In Australia, research is issued and distributed by Macquarie Securities (Australia) Ltd (AFSL No. 238947), a participating organization of the Australian Securities Exchange. Macquarie
Securities (Australia) Limited staff involved with the preparation of research have regular interaction with companies they cover. Additionally, Macquarie Group Limited does and seeks to do business with
companies covered by Macquarie Research. There are robust information barriers in place to protect the independence of Macquarie Research's product. However, recipients of Macquarie Research should
be aware of this potential conflict of interest. New Zealand: In New Zealand, research is issued and distributed by Macquarie Securities (NZ) Ltd, a NZX Firm. Canada: In Canada, research is prepared,
approved and distributed by Macquarie Capital Markets Canada Ltd., a (i) member of the Investment Industry Regulatory Organization of Canada and the Canadian Investor Protection Fund, and (ii)
participating organisation of the Toronto Stock Exchange, TSX Venture Exchange & Montréal Exchange. This research is distributed in the United States, as third party research by Macquarie Capital
Markets North America Ltd., which is a registered broker-dealer and member of Financial Industry Regulatory Authority and the Securities Investor Protection Corporation. Macquarie Capital Markets North
America Ltd. accepts responsibility for the contents of reports issued by Macquarie Capital Markets Canada Ltd. in the United States and sent to US persons. Any US person wishing to effect transactions in
the securities described in the reports issued by Macquarie Capital Markets Canada Ltd. should do so with Macquarie Capital Markets North America Ltd. This research is intended for distribution in the
United States only to major Institutional Investors (as such term is defined in SEC 15a-6 and Section 15 of the Securities Exchange Act of 1934, as amended) and is not intended for the use of any person
or entity that is not a major institutional investor. Research analysts of Macquarie Capital Markets Canada Ltd. are not registered/qualified as research analysts with FINRA. The Research Distribution Policy
of Macquarie Capital Markets Canada Ltd. is to allow all clients that are entitled to have equal access to our research. United Kingdom: In the United Kingdom, research is issued and distributed by
Macquarie Capital (Europe) Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 193905). Germany: In Germany, this research is issued and/or distributed by Macquarie Capital
(Europe) Limited, Niederlassung Deutschland, which is authorised and regulated by the UK Financial Conduct Authority (No. 193905). and in Germany by BaFin. France: In France, research is issued and
distributed by Macquarie Capital (Europe) Ltd, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority (No. 193905). Hong Kong & Mainland China: In Hong Kong,
research is issued and distributed by Macquarie Capital Limited, which is licensed and regulated by the Securities and Futures Commission. In Mainland China, Macquarie Securities (Australia) Limited
Shanghai Representative Office only engages in non-business operational activities excluding issuing and distributing research. Only non-A share research is distributed into Mainland China by Macquarie
Capital Limited. Japan: In Japan, research is issued and distributed by Macquarie Capital Securities (Japan) Limited, a member of the Tokyo Stock Exchange, Inc. and Osaka Exchange, Inc. (Financial
Instruments Firm, Kanto Financial Bureau (kin-sho) No. 231, a member of Japan Securities Dealers Association). India: In India, research is issued and distributed by Macquarie Capital Securities (India)
Pvt. Ltd. (CIN: U65920MH1995PTC090696), 92, Level 9, 2 North Avenue, Maker Maxity, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051, India, which is a SEBI registered Research Analyst
having registration no. INH000000545. Malaysia: In Malaysia, research is issued and distributed by Macquarie Capital Securities (Malaysia) Sdn. Bhd. (Company registration number: 463469-W) which is a
Participating Organisation of Bursa Malaysia Berhad and a holder of Capital Markets Services License issued by the Securities Commission. Taiwan: In Taiwan, research is issued and distributed by
Macquarie Capital Limited, Taiwan Securities Branch, which is licensed and regulated by the Financial Supervisory Commission. No portion of the report may be reproduced or quoted by the press or any
other person without authorisation from Macquarie. Nothing in this research shall be construed as a solicitation to buy or sell any security or product. The recipient of this report shall not engage in any
activities which may give rise to potential conflicts of interest to the report. Research Associate(s) in this report who are registered as Clerks only assist in the preparation of research and are not engaged in
writing the research. Macquarie may be in past one year or now being an Issuer of Structured Warrants on securities mentioned in this report. Thailand: In Thailand, research is produced, issued and
distributed by Macquarie Securities (Thailand) Ltd. Macquarie Securities (Thailand) Ltd. is a licensed securities company that is authorized by the Ministry of Finance, regulated by the Securities and
Exchange Commission of Thailand and is an exchange member of the Stock Exchange of Thailand. The Thai Institute of Directors Association has disclosed the Corporate Governance Report of Thai
Listed Companies made pursuant to the policy of the Securities and Exchange Commission of Thailand. Macquarie Securities (Thailand) Ltd does not endorse the result of the Corporate Governance
Report of Thai Listed Companies but this Report can be accessed at: http://www.thai-iod.com/en/publications.asp?type=4. South Korea: In South Korea, unless otherwise stated, research is prepared,
issued and distributed by Macquarie Securities Korea Limited, which is regulated by the Financial Supervisory Services. Information on analysts in MSKL is disclosed at:
http://dis.kofia.or.kr/websquare/index.jsp?w2xPath=/wq/fundMgr/DISFundMgrAnalystStut.xml&divisionId=MDIS03002001000000&serviceId=SDIS03002001000. South Africa: In South Africa, research is
issued and distributed by Mazi Macquarie Securities (RF) (Pty) Ltd, a member of the JSE Limited. Singapore: In Singapore, research is issued and distributed by Macquarie Capital Securities (Singapore)
Pte Ltd (Company Registration Number: 198702912C), a Capital Markets Services license holder under the Securities and Futures Act to deal in securities and provide custodial services in Singapore.
Pursuant to the Financial Advisers (Amendment) Regulations 2005, Macquarie Capital Securities (Singapore) Pte Ltd is exempt from complying with sections 25, 27 and 36 of the Financial Advisers Act.
All Singapore-based recipients of research produced by Macquarie Capital (Europe) Limited, Macquarie Capital Markets Canada Ltd, Mazi Macquarie Securities (RF) (Pty) Ltd and Macquarie Capital (USA)
Inc. represent and warrant that they are institutional investors as defined in the Securities and Futures Act. United States: In the United States, research is issued and distributed by Macquarie Capital
(USA) Inc., which is a registered broker-dealer and member of FINRA. Macquarie Capital (USA) Inc, accepts responsibility for the content of each research report prepared by one of its non-US affiliates
when the research report is distributed in the United States by Macquarie Capital (USA) Inc. Macquarie Capital (USA) Inc.’s affiliate analysts are not registered as research analysts with FINRA, may not be
associated persons of Macquarie Capital (USA) Inc., and therefore may not be subject to FINRA rule restrictions on communications with a subject company, public appearances, and trading securities held
by a research analyst account. Information regarding futures is provided for reference purposes only and is not a solicitation for purchases or sales of futures. Any persons receiving this report directly from
Macquarie Capital (USA) Inc. and wishing to effect a transaction in any security described herein should do so with Macquarie Capital (USA) Inc. Important disclosure information regarding the subject
companies covered in this report is available at www.macquarie.com/research/disclosures, or contact your registered representative at 1-888-MAC-STOCK, or write to the Supervisory Analysts, Research
Department, Macquarie Securities, 125 W.55th Street, New York, NY 10019. © Macquarie Group PAGE 38
This publication was disseminated on 13 September 2018 at 15:07 UTC.